home / stock / otlk / otlk articles

OTLK Articles, Outlook Therapeutics Inc. - From 11/05/23

Stock Information
Company Name: Outlook Therapeutics Inc.
Stock Symbol: OTLK
Market: NASDAQ
Website: outlooktherapeutics.com
Menu
OTLK OTLK Quote OTLK Short OTLK News OTLK Articles OTLK Message Board
Get OTLK Alerts

News, Short Squeeze, Breakout and More Instantly...
Pomerantz Law Firm Announces the Filing of a Class Action Against Outlook Therapeutics, Inc. and Certain Officers – OTLK | Benzinga

NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Outlook Therapeutics, Inc...
OTLK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Outlook Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Outlook Therapeutics Class Action Lawsuit | Benzinga

SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the Outlook Therapeutics class action lawsuit s...

This Analyst Upgrades Vision Disorder-Focused Outlook Therapeutics' Prospects After FDA Agreement Despite Investor Concerns | Benzinga

Thursday, Outlook Therapeutics Inc (NASDAQ: OTLK) announced it completed the requested Type A Meetings with the FDA to discuss the C...

Cyberark Software To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Crude Oil Gains Over 2%; S&P Global Raises Profit Outlook | Benzinga

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Thursday. The Dow traded up 1.51% to...

Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholder...

Why Is Retinal Disease-Focused Outlook Therapeutics Stock Plunging Today? | Benzinga

Outlook Therapeutics Inc (NASDAQ: OTLK) shares are slumping after the company announced that it has completed the requested Type A M...
Dow Jumps 400 Points; Starbucks Posts Upbeat Earnings | Benzinga

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 400 points on Thursday. The Dow traded up 1.21% to 33,...

Nasdaq Surges Over 1%; US Initial Jobless Claims Increase To 217,000 | Benzinga

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 250 points on Thursday. Following the market opening Thursday, t...

Outlook Therapeutics® to Present at Guggenheim's 5th Annual Inflammation, Neurology & Immunology (INI) Conference | Benzinga

ISELIN, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company working to achieve FDA app...
Previous 10 Next 10